Marty Makary, Commissioner of the U.S. Food and Drug Administration (FDA), shared a post on X:
“Cell and gene therapy developers shouldn’t have to guess about what safety studies FDA wants to see.
Today, FDA issued clear draft guidance that will save developers millions of dollars and years of effort, accelerating treatments to patients. Every effort to move more efficiently here is worth it.”
More posts about FDA.